La vendita allo scoperto per Doximity dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Doximity. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Doximity (NYSE:DOCS) Azioni, Report sulle vendite allo scoperto

DOXIMITY INC-CLASS A

Doximity

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

AMCX

DOCS

SATS

TTWO

Scopri i cinque titoli azionari da seguire oggi: EchoStar, Take-Two, American Axle, Doximity e AMC Networks.

Pre-market: 5 titoli da monitorare oggi, 9 agosto 2024

Doximity Inc

Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) has outperformed the market over the past 5 years by 4.58% on an annualized basis producing an average annual return of 19.6%. Currently, Option Care Health has a market capitalization of $5.42 billion. 
Buying $1000 In OPCH: If an investor had bought $1000 of OPCH stock 5 years ago, it would be worth $2,371.19 today based on a price of $33.09 for OPCH at the time of writing.
<h3>Option Care Health's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747691169_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OPCH

$1000 Invested In Option Care Health 5 Years Ago Would Be Worth This Much Today

After an impressive run over the first four months of the year, exchange-traded funds (ETFs) that invest in Treasury <a href="https://www.benzinga.com/etfs">Inflation-Protected Securities</a>, or TIPS, are now losing steam. Reason: inflation expectations, which climbed in recent months amid fears that the Trump administration&#8217;s tariffs will push up prices, have moderated somewhat, The Vanguard Short-Term Inflation-Protected Securities ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTIP#NASDAQ">VTIP</a>) has retreated about 0.75% from a high in early May, while the broader iShares TIPS Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIP#NYSE">TIP</a>) has fallen about 2.3% from its April peak. These are declines that have occurred in the context of a reset of inflation and bond-market conditions on the heels of a wave of mixed economic signals and a late-cycle credit rating shock.
Also Read:<a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45501637/stocks-mixed-treasury-bonds-slip-on-moodys-us-downgrade-whats-driving-markets-monday"> Stocks Mixed, Treasury Bonds Slip On Moody&#8217;s US Downgrade: What&#8217;s Driving Markets Monday?</a>
Inflation Expectations Cool
The TIPS retreat coincides with a moderation in inflation expectations after President Donald Trump rolled back or paused most of the elevated tariff rates announced earlier. A sustained decline in the U.S. headline inflation rate also helped temper anxiety over prices. The headline inflation rate fell to 2.3% in April, which was the lowest level in over four years. Inflation breakeven rates have also moderated. The 5-Year TIPS Breakeven Rate has dropped to 2.42% from its February high of 2.66%. The 10-Year Breakeven Rate is at around 2.34%, a decline from this year&#8217;s high of 2.46% back in February, per FRED <a href="https://fred.stlouisfed.org/graph/?id=T5YIE,T10YIE,T5YIFR">data</a>.
Moody&#8217;s Downgrade Changes Treasury Dynamics
Adding to the squeeze on TIPS ETFs is a sudden surge in real yields, led by <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45500872/30-year-treasury-yields-hit-5-what-that-means-for-stocks">Moody&#8217;s Ratings downgrade of the U.S. sovereign credit rating from Aaa to Aa1</a>. On Monday afternoon, the 10-year Treasury yield was hovering at 4.45%. The 30-year yield also rose to 4.9%.
According to Bloomberg, Franklin Templeton&#8217;s Max Gokhman issued a warning of an eventual &#8220;bear steepener spiral&#8221; as institutional investors begin to shift out of long-dated Treasuries as fears about fiscal unsustainability and higher net interest burdens continue to grow.
Outlook: TIPS In A Tight Place
The near-term outlook for TIPS continues to be pinched by two headwinds: cooling inflation expectations, which reduce the attractiveness of inflation-indexed bonds, and increasing real yields, which debase the market value of TIPS, particularly longer-duration ones like TIP.
Unless inflation reaccelerates or a bond market turmoil inspires a flight to safety, TIPS ETFs can continue to lag relative to nominal Treasuries and equity-linked inflation hedges.
Inflation is no longer the villain, it&#8217;s the Treasury market&#8217;s own internal contradictions that are roiling the stage.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45503887/quantum-vs-ai-nvidias-next-big-bet-could-supercharge-these-2-etfs">Quantum Vs AI: Nvidia&#8217;s Next Big Bet Could Supercharge These 2 ETFs</a></li>
</ul>
Photo: Shutterstock

Bonds

Specialty ETFs

ETFs

VTIP

TIPS In Trouble: Why Inflation-Protected Bond ETFs Are Losing Their Spark

WIIM

EYEN

Eyenovia shares are trading higher after the company provided an update on its merger with Betaliq. The company also reported better-than-expected Q1 EPS results.

Potential Merger with Betaliq
Negotiations continue towards a binding merger agreement with Betaliq, a clinical-stage private pharmaceutical company focused on glaucoma with access to Eyesol&reg;, a non-aqueous technology that may address many of the needs of these patients. We have agreed to extend the binding exclusivity period set forth in the Letter of Intent until June 7, 2025, to allow more time to complete and execute the anticipated merger agreement.
Development of the Optejet UFD
Progress in the development of the Optejet user-filled device (UFD) continues and remains on track to file for U.S. regulatory approval in September of this year. An approval would provide for potential multiple commercial opportunities either directly with consumers or through eye care practitioner offices as well as potential and existing license partners, including Arctic Vision in China and Korea.

Eyenovia Provides Updates On Potential Merger With Betaliq And Development Of The Optejet User Filled Device; Says Co's Continue To Negotiate A Binding Merger Agreement, Have Agreed To Extend The Binding Exclusivity Period Set Forth In The Letter Of Intent Until June 7, 2025

Earnings Beats

Earnings Misses

GIPR

Generation Income Q1 FFO $(0.03) Misses $0.02 Estimate, Sales $2.38M Beat $2.17M Estimate

ASP Isotopes Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) shares are trading higher in Monday&#8217;s after-hours session after the company announced loan and supply agreements with <a href="https://www.benzinga.com/pressreleases/25/05/g45505949/asp-isotopes-inc-enters-into-definitive-agreements-with-terrapower-including-loan-agreement-for-co">Bill Gates-backed </a><a href="https://www.benzinga.com/pressreleases/25/05/g45505949/asp-isotopes-inc-enters-into-definitive-agreements-with-terrapower-including-loan-agreement-for-co">TerraPower</a>.
What Happened: After the market close on Monday, ASP Isotopes announced that it entered into multiple definitive agreements with nuclear company TerraPower for financing support related to the construction of a new uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (HALEU).
The company signed a loan agreement that provides conditional commitments from TerraPower to the company for a multiple-advance term loan.
ASP Isotopes and TerraPower also entered into two supply agreements for the HALEU expected to be produced at the company&#8217;s uranium enrichment facility. One is an initial core supply agreement and the other is a long-term supply agreement, starting in 2028 and running through the end of 2037, for up to 150 metric tons of HALEU.
&#8220;Nuclear fuel has one of the most severely compromised supply chains of any material in the world. The world is in urgent need of additional suppliers. Over the next several years our goal is to use our technologies to solve many of the supply challenges which currently exist,&#8221; said Paul Mann, chairman and CEO of ASP Isotopes.
&#8220;Our commercial agreement with TerraPower will enable us to accelerate the construction of an advanced nuclear fuel facility.&#8221;
ASP Isotopes shares <a href="https://www.benzinga.com/news/24/10/41624818/asp-isotopes-stock-is-soaring-wednesday-whats-going-on">surged</a> in October 2024 after the company entered into a term sheet with TerraPower&nbsp;related to the same agreements. The term sheet contemplated the preparation of the definitive agreements announced on Monday. 
ASPI Price Action: <a href="http://benzinga.com/quote/ASPI">ASP Isotopes shares</a> were up 7.85% after-hours trading Monday, at $8.11 at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45378427/trump-wants-to-kickstart-nuclear-development-these-5-stocks-could-boom">Trump Wants To Kickstart Nuclear Development: These 5 Stocks Could Boom</a></li>
</ul>
Photo: Shutterstock.

Contracts

After-Hours Center

Movers

ASPI

ASP Isotopes Stock Is Surging After Hours: Here's Why

Flanigan'S Enterprises (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BDL#AMEX">BDL</a>) reported quarterly earnings of $1.45 per share. This is a 39.42 percent increase over earnings of $1.04 per share from the same period last year. The company reported $53.63 million in sales this quarter. This is a 11.57 percent increase over sales of $48.07 million the same period last year.

Flanigan'S Enterprises Q2 EPS $1.45 Up From $1.04 YoY, Sales $53.63M Up From $48.07M YoY

GIPRW

Trading Halt: Halt status updated at 5:35:00 PM ET: Quotation Resumption: News and Resumption Times

Eyenovia Q1 EPS $(1.59) Beats $(9.60) Estimate, Sales $14.72K

General

Generation Income Properties Says It Has Initiated A Review Of Strategic Alternatives For The Company To Identify Opportunities To Maximize Value For The Company's Shareholders

Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) has outperformed the market over the past 15 years by 9.74% on an annualized basis producing an average annual return of 21.8%. Currently, Intuit has a market capitalization of $187.55 billion. 
Buying $1000 In INTU: If an investor had bought $1000 of INTU stock 15 years ago, it would be worth $19,433.95 today based on a price of $670.86 for INTU at the time of writing.
<h3>Intuit's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747690227_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INTU

Here's How Much You Would Have Made Owning Intuit Stock In The Last 15 Years

Trading Halt: Halt status updated at 5:30:00 PM ET: Quotation Resumption: News and Resumption Times

Qualigen Therapeutics, Inc. - Common Stock

QLGN

Qualigen Therapeutics Receives Notice Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Report On Form 10-Q

TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31 by 9.68 percent. This is a 78.95 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $42.14 million which beat the analyst consensus estimate of $41.70 million by 1.06 percent. This is a 23.63 percent increase over sales of $34.09 million the same period last year.

TATT

TAT Techs Q1 EPS $0.34 Beats $0.31 Estimate, Sales $42.14M Beat $41.70M Estimate

PEGA

Pegasystems shares are trading higher after it was announced that the company will join the S&P Midcap 400 On May 22, 2025.

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250519-1478064/1478064_4jwn.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250519-1478064/1478064_4jwn.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250519-1478064/1478064_4jwn.pdf</a>

Pegasystems Will Replace Nordstrom In The S&P Midcap 400 Effective Prior To The Opening Of Trading On May 22, 2025

It's no secret that real estate brokerage and mortgage origination service provider Redfin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) is struggling. Although its year-to-date performance is impressive, RDFN stock is down 66% in the trailing five years. The equity is also a fraction of its February 2021 peak — a victim of soaring inflation, high interest rates and now, <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45263291/fed-keeps-rates-steady-warns-of-rising-uncertainty-about-the-economic-outlook">broader economic uncertainty</a>. Still, with so much bad news baked in, any positive developments could have an exponentially strong effect.
Fundamentally, analysts refer to the above concept as value compression. After a severe decline in a publicly traded security, expectations for the underlying company are deflated. Subsequently, a small positive catalyst can cause a snapback rally. For RDFN stock, the main catalysts revolve around the benchmark interest rate and global trade policies. Even better, there are legitimate reasons for optimism.
Regarding interest rates, the Federal Reserve is keeping a watchful eye on core economic metrics. Should conditions justify a more accommodative policy, it's possible — perhaps likely — that the Fed will respond with a dovish approach. A step toward lower rates could accelerate sentiment in RDFN stock, given how deflated it already is.
As for trade policies, President Donald Trump's tariffs have created uncertainty in the housing market, particularly in the realm of implied <a href="https://www.benzinga.com/news/econ-s/25/04/44795415/trumps-tariffs-could-send-rents-higher-economist-warns">higher building material costs</a>. At the same time, the administration appears to be making progress, recently striking a <a href="https://www.benzinga.com/media/25/05/45481159/donald-trump-offers-to-visit-xi-jinping-in-beijing-calls-us-china-ties-important-after-striking-temporary-trade-truce">temporary trade truce with China</a>.
Put another way, it's possible that the bulk of the bad news is in the rearview mirror. Therefore, the few inches of momentum that the economy is able to generate could spark outsized returns for Redfin.
<h2 class="wp-block-heading">Market Breadth Data Signals Optimism For RDFN Stock</h2>
Although the narrative for Redfin's business may finally have reached a turning point, traders seeking to extract alpha from RDFN stock need far more reliable clues than deciphering talking points. It's here where market breadth data — essentially analyzing the accumulation and distribution of demand — becomes invaluable.
In the past 10 weeks, RDFN stock printed a "7-3-U" sequence: seven up weeks mixed with three down weeks, with a net positive trajectory across the period. This bullish-dominated sequence has materialized 53 times since Redfin's initial public offering. Significantly, in 62.26% of cases, the following week's price action results in upside, with a median return of 4.86%.
To put this framework in colloquial terms, the deck has become hot, thus incentivizing a bullish wager. In any given week, the chance that a long position in RDFN stock will be profitable is only 48.8%. Stated differently, RDFN natively features a negative bias. Therefore, when traders buy Redfin options, the premiums reflect this pessimistic propensity.
However, under certain conditions, the probability of forward momentum in RDFN stock can vary significantly from the baseline probability. And that's what the 7-3-U market breadth data signals to the speculator. It's not a special indicator, per se. Rather, when this sequence appears, RDFN behaviorally transitions from a statistically poor wager (from the bull's perspective) to a favorable one.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19143026/RDFN-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-920228" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19143026/RDFN-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19143026/RDFN-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19143026/RDFN-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19143026/RDFN-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Assuming that the bulls take control of the market, RDFN stock could potentially hit $10.64 in a week or two. Speculators can then use this forecast to plot an effective options strategy.
<h2 class="wp-block-heading">Taking a Quick Swing at Redfin</h2>
Traders seeking a quick boost may consider the 10/10.50 bull call spread expiring May 30. This transaction involves buying the $10 call and simultaneously selling the $10.50 call. The proceeds from the short call partially offset the debit paid for the long call, resulting in a net debit paid of $32, the most that can be lost in the trade.
Should RDFN stock rise through the short strike price of $10.50 at expiration, the maximum reward for the aforementioned bulls spread is $18, a payout of over 56%.
What makes this trade attractive is that from a nominal perspective, the risk is quite minimal. At $32, traders can nibble at this spread with pocket change. From a probabilistic angle, the better holds an underappreciated advantage. Most of the market assumes that the bears have the statistical edge — which would be true in the average case.
However, RDFN is responding to a specific market breadth setup and that could make all the difference in this trade.
Read Next:
<a href="https://www.benzinga.com/top-stories/25/05/45476901/political-turmoil-bmy-stock-contrarian-bull-call-spread">Options Corner: Political Turmoil Sets Up A Contrarian Call Spread For Bristol-Myers Squibb</a>
Photo: Shutterstock

Equities

Long Ideas

Options

RDFN

Options Corner: Redfin's Value Compression Sets The Stage For A Bullish Bounce Back

VTAK

Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co; May Sell Up To $1.3M In Common Stock

Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has outperformed the market over the past 10 years by 26.43% on an annualized basis producing an average annual return of 37.37%. Currently, Strategy has a market capitalization of $114.25 billion. 
Buying $1000 In MSTR: If an investor had bought $1000 of MSTR stock 10 years ago, it would be worth $23,926.15 today based on a price of $413.01 for MSTR at the time of writing.
<h3>Strategy's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747689312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSTR

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

President Donald Trump's sweeping legislative package is, as expected, divisive. Republicans are pitching it as &#8220;One, Big Beautiful Bill.&#8221; Democrats are <a href="https://www.youtube.com/watch?v=D2cwPUb21IE">calling it</a> &#8220;one big beautiful betrayal.&#8221; Here's a look at some of the bill&#8217;s <a href="https://www.benzinga.com/personal-finance/25/05/45485150/the-one-big-beautiful-bill-would-create-maga-savings-accounts-with-a-1000-gift-from-the-government-at-birth">key elements</a>.&nbsp;
The Winners: The bill seeks to extend The Tax Cuts and Jobs Act (TCJA) of 2017. That means the expiring provisions that benefit high-income and wealthy earners would be permanent.
It also seeks to eliminate federal taxes on tips and overtime pay, fulfilling some of Trump&#8217;s campaign promises.&nbsp;
The tax breaks would reduce revenue by $4.9 trillion over the decade, but increase spending on military, defense and border security. 
So, if legislators sign the bill into law, major U.S. defense contractors like RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) and Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) could benefit from increased defense spending.&nbsp;
Other companies exposed to the defense sector including Palantir Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) and Booz Allen Hamilton Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) could also benefit from increased military and defense spending.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45499101/big-short-legend-michael-burry-bets-big-on-lipstick-index-is-he-bracing-for-a-recession?utm_source=article">&#8216;Big Short&#8217; Legend Michael Burry Bets Big On Lipstick Index: Is He Bracing For A Recession?</a>
The Losers: The cost of the tax bill will be partially balanced with new taxes on private university endowments and significant cuts to programs like Medicaid.
Stocks of major Medicaid managed care organizations could be vulnerable to enrollment volatility and premium pricing challenges if the changes are approved. Investors would be wise to monitor UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) and Elevance Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) as the bill moves through Congress. 
Low-income Americans who rely on food assistance should also take note. House Republicans are proposing major changes to the Supplemental Nutrition Assistance Program, or SNAP. The program aids over 42 million Americans. The bill would shift 5% of benefit costs and 75% of administrative costs to states, up from the current 50% share for administration only. It also seeks to expand work requirements to recipients up to age 64.
Democrats have criticized the move as harmful to families, while Republicans say it promotes work and cuts waste. The House Agriculture Committee has already <a href="https://www.politico.com/live-updates/2025/05/14/congress/house-agriculture-committee-approves-300-billion-in-nutrition-spending-cuts-00350900">approved</a> $300 million in SNAP cuts to help fund tax breaks.
If the<a href="https://www.benzinga.com/general/health-care/25/05/45431505/gop-tax-bill-breaks-trumps-social-security-tax-pledge-still-hits-25-million-seniors-while-elon-musks-stock-wealth-skirts-fica"> legislative package</a> is passed, it would also be the end of many clean energy initiatives and key tax credits and would impose new fees on electric vehicles. These changes could slow the growth of the clean energy sector and make electric vehicles and renewables less competitive compared to traditional energy sources.&nbsp;
Clean energy stocks including Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) and Sunrun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) were all sharply lower on Monday as investors digested the potential effects on the industry.&nbsp;
The 1,116-page bill also wouldn&#8217;t quell fears about America&#8217;s public debt, which currently stands at $36 trillion. According to the nonpartisan watchdog group, the Committee for a Responsible Federal Budget, the bill <a href="https://www.crfb.org/blogs/adding-house-reconciliation-bill">adds</a> approximately $3.3 trillion to the national debt over the next ten years.
What's Next: After advancing out of the House Budget Committee in a rare Sunday meeting by a narrow 17-16 vote, Trump&#8217;s &#8220;One Big, Beautiful Bill&#8221; faces several<a href="https://www.benzinga.com/25/05/45481745/donald-trump-backed-gop-bill-seeks-to-ban-states-from-regulating-ai-for-10-years-critics-warn-its-federal-overreach-that-could-backfire"> key steps</a> before it can become law.
The next stop is the House Rules Committee, which will meet midweek to set the terms for floor debate, consider possible amendments, and make any necessary last-minute adjustments to the bill before it heads to a full vote on the House floor. 
If the bill passes the House, it will move to the Senate where it may face additional challenges, as Republican senators are also seeking changes that could complicate final passage.
Further changes to the bill are possible as leaders work to secure enough support from both conservative and moderate factions.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45384935/trump-again-promises-lower-drug-prices-by-cutting-out-middlemen-like-unitedhealth-cvs-will-it-work-this-time?utm_source=articleShare">Trump Again Promises Lower Drug Prices By &#8216;Cutting Out Middlemen&#8217; Like UnitedHealth, CVS: Will It Work This Time?</a></li>
</ul>
Photo: Shutterstock&nbsp;

Government

Large Cap

Regulations

Health Care

Politics

Tech

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

ENPH

FSLR

PLTR

Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses

Legal

Press Releases

DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

Doximity Announces Fiscal 2025 Third Quarter Financial Results

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

Comments

Doximity

Vendite allo scoperto

Doximity (NYSE:DOCS) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO